BioAffinity Historical Valuation

BIAFW Stock  USD 0.75  0.15  24.40%   
Some fundamental drivers such as market cap or BioAffinity Technologies enterprice value can be analyzed from historical perspective to project value of the company into the future. Some investors analyze BioAffinity Technologies valuation indicators such as Working Capital of 0.0 or Enterprise Value of 11 M to time the market or to short-sell their positions based on the trend in valuation ratios. It is a perfect tool to project the direction of BioAffinity Technologies's future value.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in bioAffinity Technologies Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

About BioAffinity Valuation Data Analysis

Valuation is the financial process of determining what BioAffinity Technologies is worth. BioAffinity Technologies valuation ratios put that insight into the context of a company's share price, where they serve as useful tools for evaluating and utilizing investment potential. BioAffinity Technologies valuation ratios help investors to determine whether BioAffinity Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioAffinity with respect to the benefits of owning BioAffinity Technologies security.

BioAffinity Technologies Valuation Data Chart

Enterprise Value is likely to drop to about 11 M in 2024

Enterprise Value

Enterprise Value (or EV) is usually referred to as BioAffinity Technologies theoretical takeover price. In the event of an acquisition, an acquirer would have to take on BioAffinity Technologies debt, but would also pocket its cash. Enterprise Value is more accurate representation of BioAffinity Technologies value than its market capitalization because it takes into account all of bioAffinity Technologies Warrant existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.